{"id":"albendazole-pill","safety":{"commonSideEffects":[{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Elevated liver enzymes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Albendazole is a benzimidazole anthelmintic that selectively binds to β-tubulin in parasitic nematodes and cestodes, preventing microtubule assembly. This disrupts glucose uptake and energy metabolism in the parasite, leading to immobilization and eventual death. The drug has selective toxicity for parasites over mammalian cells due to differences in tubulin binding affinity.","oneSentence":"Albendazole inhibits microtubule polymerization in parasitic worms by binding to β-tubulin, disrupting their cellular structure and causing paralysis and death.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:00:33.057Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Helminthic infections including Ascaris lumbricoides, Trichuris trichiura, Necator americanus, Ancylostoma duodenale"},{"name":"Echinococcosis (hydatid disease)"},{"name":"Neurocysticercosis"}]},"trialDetails":[{"nctId":"NCT04966702","phase":"PHASE3","title":"Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)","status":"COMPLETED","sponsor":"Barcelona Institute for Global Health","startDate":"2022-03-17","conditions":"Malaria","enrollment":48145},{"nctId":"NCT04041427","phase":"NA","title":"Urine Albendazole Levels for Coverage Assessment","status":"COMPLETED","sponsor":"Universidad Nacional de Salta","startDate":"2019-07-17","conditions":"Helminthiasis","enrollment":12},{"nctId":"NCT03079388","phase":"NA","title":"Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-02-27","conditions":"Pregnancy, Malnutrition in Pregnancy, Nutrition Disorders","enrollment":1489},{"nctId":"NCT03465488","phase":"NA","title":"Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic Resistance","status":"COMPLETED","sponsor":"University Ghent","startDate":"2016-08-15","conditions":"Soil-transmitted Helminth Infections","enrollment":1000},{"nctId":"NCT02078024","phase":"PHASE3","title":"Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2014-06","conditions":"Onchocerciasis","enrollment":375},{"nctId":"NCT03238131","phase":"PHASE3","title":"IVM Alone vs ALB + IVM Against Onchocerciasis","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2012-04","conditions":"Onchocerciasis","enrollment":272},{"nctId":"NCT01070277","phase":"NA","title":"Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2012-03","conditions":"Chronic Diarrhea, Abdominal Pain, Bloating","enrollment":100},{"nctId":"NCT01440608","phase":"NA","title":"Effectiveness of High-dose Zinc Therapy and Albendazole in the Treatment of Environmental Enteropathy","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2011-10","conditions":"Enteropathy","enrollment":225}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Alben, Bendex"],"phase":"phase_3","status":"active","brandName":"Albendazole Pill","genericName":"Albendazole Pill","companyName":"Universidad Nacional de Salta","companyId":"universidad-nacional-de-salta","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Albendazole inhibits microtubule polymerization in parasitic worms by binding to β-tubulin, disrupting their cellular structure and causing paralysis and death. Used for Helminthic infections including Ascaris lumbricoides, Trichuris trichiura, Necator americanus, Ancylostoma duodenale, Echinococcosis (hydatid disease), Neurocysticercosis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}